Tg Therapeutics Income Statement (2016-2025) | TGTX

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue -0.20M-0.18M-0.17M0.28M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.79M1.54M2.03M2.32M2.02M0.59M0.09M0.08M7.80M16.07M165.81M43.97M63.47M73.47M83.88M108.19M120.86M141.15M161.71M
Cost of Revenue 0.14M0.00M0.00M0.86M1.91M3.51M7.85M5.44M8.30M9.34M15.40M15.54M18.94M28.09M
Gross Profit 0.65M0.09M0.08M6.95M14.16M162.31M36.12M58.03M65.16M74.54M92.79M105.31M122.21M133.62M
Operating items
Research & Development 11.62M13.53M21.80M22.28M22.68M27.15M26.00M35.02M38.70M33.40M52.28M32.38M32.87M57.98M30.94M36.02M36.45M50.46M42.96M63.09M44.87M51.97M62.65M48.04M26.87M20.80M29.64M15.87M28.12M14.75M17.45M32.72M17.56M20.14M23.87M46.36M31.78M40.88M
Selling, General & Administrative 2.41M2.53M3.17M1.78M5.02M4.47M5.08M6.60M5.68M0.97M1.91M2.34M2.72M2.91M7.06M14.26M14.43M35.30M43.86M26.76M34.02M34.90M32.41M20.61M12.64M14.25M47.98M28.07M30.71M32.77M31.15M34.58M38.79M41.97M38.96M50.33M55.59M63.37M
Restructuring Costs 1.10M1.45M1.25M1.32M1.33M1.40M1.77M2.12M2.31M1.78M1.66M1.95M2.31M2.32M2.92M5.17M8.62M11.58M16.15M
Other Operating Expenses -1.10M-1.45M-1.25M-1.32M-1.33M-1.40M-1.77M-2.12M-2.31M-1.78M-1.66M-1.95M-2.31M-2.32M-2.92M-5.17M-8.62M-11.58M-16.15M0.14M0.15M0.29M0.21M0.24M0.02M0.00M0.00M0.86M1.91M3.51M7.85M5.44M8.30M9.34M15.40M15.54M18.94M28.09M
Operating Expenses 14.03M16.06M24.96M24.07M27.70M31.62M31.07M41.62M44.38M34.37M54.19M34.73M35.58M60.90M38.00M50.28M50.88M85.76M86.82M90.00M79.04M87.16M95.27M68.89M39.53M35.06M77.62M44.80M60.75M51.03M56.46M72.74M64.65M71.44M78.24M112.23M106.31M132.34M
Operating Income -13.99M-16.02M-24.93M-24.03M-27.67M-31.59M-31.04M-41.58M44.34M-34.33M-54.15M-34.69M-35.54M-60.86M-37.96M-50.24M-50.84M-85.72M-86.78M-89.20M-77.49M-85.13M-92.95M-66.87M-38.94M-34.96M-77.54M-36.99M-44.67M114.78M-12.48M-9.27M8.82M12.43M29.95M8.62M34.84M29.36M
EBIT -13.99M-16.02M-24.93M-24.03M-27.67M-31.59M-31.04M-41.58M44.34M-34.33M-54.15M-34.69M-35.54M-60.86M-37.96M-50.24M-50.84M-85.72M-86.78M-89.20M-77.49M-85.13M-92.95M-66.87M-38.94M-34.96M-77.54M-36.99M-44.67M114.78M-12.48M-9.27M8.82M12.43M29.95M8.62M34.84M29.36M
Non-operating items
Interest & Investment Income 0.08M0.09M0.09M0.06M0.04M0.08M0.12M0.14M0.22M0.26M0.27M0.15M1.08M
Other Non Operating Income 0.30M0.25M0.18M0.79M1.93M0.60M0.69M2.86M0.89M0.88M1.71M2.67M2.56M3.60M2.79M3.27M
Non Operating Income 0.14M0.12M0.09M0.35M-0.06M0.05M0.17M0.05M0.20M-0.38M1.55M-0.47M-0.67M-1.07M-1.61M-0.87M-2.04M-1.44M-1.44M-1.43M-1.00M-0.51M-0.39M-2.14M-1.57M-0.85M-0.93M-2.24M-2.94M2.86M-1.54M-1.41M-2.27M-8.17M-4.50M3.60M-3.92M-3.46M
Net income details
EBT -14.15M-16.15M-25.05M-23.97M-27.62M-31.51M-30.91M-41.43M44.57M-34.29M-54.10M-35.31M-35.54M-62.40M-39.86M-51.45M-53.07M-87.33M-88.07M-91.10M-79.11M-86.17M-94.03M-69.54M-41.96M-36.61M-80.40M-39.23M-47.61M113.93M-14.03M-10.68M6.55M4.27M25.45M5.47M30.92M25.91M
Tax Provisions 0.39M0.03M-0.33M0.40M2.11M0.41M2.73M-365.00M
Profit After Tax -13.85M-15.90M-24.83M-23.67M-27.73M-31.54M-30.86M-41.53M-44.14M-33.95M-53.86M-35.16M-36.21M-61.93M-39.57M-51.12M-52.88M-87.16M-88.22M-90.63M-78.50M-85.64M-93.34M-69.01M-40.51M-35.82M-78.47M-39.23M-47.61M113.93M-14.42M-10.71M6.88M3.88M23.33M5.06M28.19M390.89M
Income from Continuing Operations -14.15M-16.15M-25.05M-23.97M-27.62M-31.51M-30.91M-41.43M44.57M-34.29M-54.10M-35.31M-35.54M-62.40M-39.86M-51.45M-53.07M-87.33M-88.07M-91.10M-79.11M-86.17M-94.03M-69.54M-41.96M-36.61M-80.40M-39.23M-47.61M113.93M-14.42M-10.71M6.88M3.87M23.34M5.06M28.19M390.91M
Consolidated Net Income -14.15M-16.15M-25.05M-23.97M-27.62M-31.51M-30.91M-41.43M44.57M-34.29M-54.10M-35.31M-35.54M-62.40M-39.86M-51.45M-53.07M-87.33M-88.07M-91.10M-79.11M-86.17M-94.03M-69.54M-41.96M-36.61M-80.40M-39.23M-47.61M113.93M-14.42M-10.71M6.88M3.87M23.34M5.06M28.19M390.91M
Income towards Parent Company -14.15M-16.15M-25.05M-23.97M-27.62M-31.51M-30.91M-41.43M44.57M-34.29M-54.10M-35.31M-35.54M-62.40M-39.86M-51.45M-53.07M-87.33M-88.07M-91.10M-79.11M-86.17M-94.03M-69.54M-41.96M-36.61M-80.40M-39.23M-47.61M113.93M-14.42M-10.71M6.88M3.87M23.34M5.06M28.19M390.91M
Net Income towards Common Stockholders -14.15M-16.15M-25.05M-23.97M-27.62M-31.51M-30.91M-41.43M44.57M-34.29M-54.10M-35.31M-35.54M-62.40M-39.86M-51.45M-53.07M-87.33M-88.07M-91.10M-79.11M-86.17M-94.03M-69.54M-41.96M-36.61M-80.40M-39.23M-47.61M113.93M-14.42M-10.71M6.88M3.87M23.34M5.06M28.19M390.91M
Additional items
EPS (Basic) -0.28-0.33-0.50-0.49-0.51-0.48-0.46-0.590.59-0.43-0.68-0.43-0.42-0.69-0.44-0.48-0.47-0.73-0.72-0.69-0.59-0.65-0.70-0.49-0.29-0.26-0.57-0.28-0.340.80-0.10-0.070.050.030.160.030.192.69
EPS (Weighted Average and Diluted) -0.76-0.69-0.60-0.65-0.71-0.52-0.31-0.26-0.57-0.28-0.280.73-0.10-0.070.040.020.150.030.172.43
Shares Outstanding (Weighted Average) 54.10M54.34M54.46M54.73M56.91M66.78M68.84M70.65M75.58M78.01M82.82M82.90M83.87M90.84M94.76M99.56M109.40M113.75M126.65M131.49M140.59M141.47M142.83M142.94M142.82M144.44M145.27M145.34M146.36M149.40M150.98M151.41M154.42M154.54M155.67M155.67M157.07M158.76M158.67M
Shares Outstanding (Diluted Average) 115.33M131.90M132.07M132.35M132.22M134.40M134.78M135.33M135.41M140.31M141.50M
EBITDA -13.99M-16.02M-24.93M-24.03M-27.67M-31.59M-31.04M-41.58M44.34M-34.33M-54.15M-34.69M-35.54M-60.86M-37.96M-50.24M-50.84M-85.72M-86.78M-89.20M-77.49M-85.13M-92.95M-66.87M-38.94M-34.96M-77.54M-36.99M-44.67M114.78M-12.48M-9.27M8.82M12.43M29.95M8.62M34.84M29.36M
Interest Expenses 0.24M0.22M0.21M0.22M0.22M0.77M1.08M1.54M1.90M1.20M2.23M1.61M1.29M1.90M1.62M1.04M1.08M2.66M3.02M1.65M2.86M2.84M3.63M3.71M2.43M2.29M3.98M10.83M7.06M6.76M6.72M6.72M
Tax Rate 9.37%8.29%7.46%8.84%